Charles River Laboratories Intl. Inc (CRL) Stock Price Today
Aura AI Summary
Key Stats
- $13.43BMarket Cap
- -Volume
- HealthSector
- $284.3752W High
- $145.5752W Low
- -Typical Hold Time
- $16.26BEnterprise Value
- -Div Yield
- -Trading Activity
Track Charles River Laboratories Intl. Inc (CRL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $145.57 and a high of $284.37, highlighting its annual price range. Buy and sell Charles River Laboratories Intl. Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Most Recent News
Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.
Several leading stocks, including SoundThinking, TSS, and ADI Global Distribution, dropped significantly due to factors like lowered revenue forecasts and disappointing quarterly results. SoundThinking fell over 25% after cutting its revenue outlook ...
Definitive Healthcare posts a stellar 41.44% ROIC, far surpassing its 5.78% capital cost.
Definitive Healthcare Corp. stands out with a remarkable Return on Invested Capital (ROIC) of 41.44%, significantly exceeding its Weighted Average Cost of Capital (WACC) of 5.78%. This means the company generates over seven times the value for every ...
Court allows securities fraud claims against Symbotic and CEO to proceed over misleading deployment progress.
A federal court has allowed securities fraud claims against Symbotic Inc. and its CEO Richard B. Cohen to move forward. The claims allege that Symbotic misled investors about accelerating its warehouse automation system deployments, despite ongoing d...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.